Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer
Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This study evaluate the addition of metformin to standard of care in locally advanced and
metastatic prostate cancer, half the patient will receive metformin in combination with
standard treatment, and the other half will receive the standard of care only